EnviTec Biogas (ETR:ETG) First Half 2024 Results
Key Financial Results
- Revenue: €190.6m (up 24% from 1H 2023).
- Net income: €22.6m (down 28% from 1H 2023).
- Profit margin: 12% (down from 20% in 1H 2023). The decrease in margin was driven by higher expenses.
All figures shown in the chart above are for the trailing 12 month (TTM) period
EnviTec Biogas shares are down 2.2% from a week ago.
Risk Analysis
Be aware that EnviTec Biogas is showing 1 warning sign in our investment analysis that you should know about...
Valuation is complex, but we're here to simplify it.
Discover if EnviTec Biogas might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:ETG
EnviTec Biogas
Manufactures and operates biogas and biomethane plants in Germany, Italy, Great Britain, the Czechia Republic, France, Denmark, the United States, China, Greece, Estonia, and internationally.
Excellent balance sheet and fair value.
